Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2NIH 1

Study Type

Interventional 3Observational 2

Sponsor

Conditions

Breast Neoplasms 468Neoplasms 316Carcinoma, Non-Small-Cell Lung 269Prostatic Neoplasms 215Colorectal Neoplasms 208Lung Neoplasms 178Multiple Myeloma 123Melanoma 110Carcinoma, Renal Cell 107Ovarian Neoplasms 94Carcinoma, Hepatocellular 78Pancreatic Neoplasms 69Urinary Bladder Neoplasms 65Stomach Neoplasms 64Neoplasm Metastasis 64Leukemia, Lymphocytic, Chronic, B-Cell 62Colonic Neoplasms 60Leukemia, Myeloid, Acute 53Uterine Cervical Neoplasms 50Recurrence 49Liver Neoplasms 46Lymphoma, Follicular 45Lymphoma 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Esophageal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Large B-Cell, Diffuse 35Hematologic Neoplasms 35Head and Neck Neoplasms 35Lymphoma, Non-Hodgkin 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Constriction, Pathologic × Clear all
NCT01613144 2022-02-25

EVOLVE

Alphatec Spine, Inc.

Completed
94 enrolled

Bone Diseases, Metabolic, Constriction, Pathologic, Neoplasms, Osteoporosis

NCT04848376 2021-04-19

Post-Market Clinical Follow-up Study of A-SPINE's Products

A-Spine Asia Co., Ltd.

Unknown
200 enrolled

Congenital Abnormalities, Constriction, Pathologic, Kyphosis, Neoplasms, Scoliosis, Wounds and Injuries, Intervertebral Disc Degeneration

Data powered by HemOnc (CC BY 4.0) Colophon âš¡